Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 242 entries
View as:

Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00813774 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Phase: N/A Priority: Normal
NCT ID: NCT00152425 Org: User:
Start: 02/29/04 End: 05/31/05 Due: 05/31/06

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00135993 Org: User:
Start: 05/31/05 End: 11/30/06 Due: 11/30/07

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01646255 Org: User:
Start: 07/31/12 End: 10/31/14 Due: 10/31/15

Alprostadil in Maculopathy Study (AIMS)

Phase: N/A Priority: Normal
NCT ID: NCT00619229 Org: User:
Start: 07/31/06 End: 02/28/10 Due: 02/28/11

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

Phase: N/A Priority: Normal
NCT ID: NCT00315523 Org: User:
Start: 07/31/06 End: 10/31/06 Due: 10/31/07

UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)

Phase: N/A Priority: Normal
NCT ID: NCT00345475 Org: User:
Start: 12/31/04 End: 05/31/16 Due: 05/31/17

Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00544154 Org: User:
Start: 10/31/02 End: 01/31/04 Due: 01/31/05

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

Phase: N/A Priority: Normal
NCT ID: NCT01330290 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00519532 Org: User:
Start: 07/31/07 End: 05/31/09 Due: 05/31/10

Named Patient Program With Rotigotine Transdermal System

Phase: N/A Priority: Normal
NCT ID: NCT01095484 Org: User:
Start: 11/30/08 End: 12/31/12 Due: 12/31/13

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00525278 Org: User:
Start: 08/31/03 End: 10/31/03 Due: 10/31/04

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Phase: N/A Priority: Normal
NCT ID: NCT00152373 Org: User:
Start: 07/31/04 End: 05/31/05 Due: 05/31/06

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Phase: N/A Priority: Normal
NCT ID: NCT00368069 Org: User:
Start: 08/31/06 End: 05/31/07 Due: 05/31/08

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT01969851 Org: User:
Start: 02/13/14 End: 04/10/18 Due: 04/10/19

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00160550 Org: User:
Start: 09/30/01 End: 06/30/05 Due: 06/30/06

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00521170 Org: User:
Start: 11/30/04 End: 01/31/05 Due: 01/31/06

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01964573 Org: User:
Start: 12/31/06 End: 02/28/07 Due: 02/28/08

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00861042 Org: User:
Start: 04/30/02 End: 03/31/05 Due: 03/31/06

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00501969 Org: User:
Start: 08/31/04 End: 12/31/08 Due: 12/31/09

Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).

Phase: N/A Priority: Normal
NCT ID: NCT00291655 Org: User:
Start: 06/30/06 End: 04/30/08 Due: 04/30/09

Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.

Phase: N/A Priority: Normal
NCT ID: NCT00546351 Org: User:
Start: 05/31/04 End: 01/31/11 Due: 01/31/12

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00552305 Org: User:
Start: 08/31/01 End: 02/28/10 Due: 02/28/11

Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00152412 Org: User:
Start: 06/30/04 End: 12/31/04 Due: 12/31/05

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Phase: N/A Priority: Normal
NCT ID: NCT00521131 Org: User:
Start: 09/30/02 End: 05/31/03 Due: 05/31/04